Obsidian ASG autologous platelet-rich fibrin matrix for the prevention of postoperative pancreatic fistula following pancreatic resection: study protocol for a feasibility trial at the Medical University of Vienna
The trial was registered in the German Clinical Trials Register on 6 May 2024 (DRKS-ID: DRKS00034052).
Authors
- Stefan Riss (ORCID: https://orcid.org/0000-0003-4039-2849)
- Charlotte Gustorff (ORCID: https://orcid.org/0009-0007-1172-0942)
- Ulla Klaiber (ORCID: https://orcid.org/0000-0002-9287-1174)
- Martin Schindl (ORCID: https://orcid.org/0000-0003-0941-2127)
- Christopher Dawoud (ORCID: https://orcid.org/0000-0003-1432-2804)
- Oliver Strobel (ORCID: https://orcid.org/0000-0001-5100-8449)
- Carl-Stephan Leonhardt (ORCID: https://orcid.org/0009-0001-7179-9580)
- Klaus Sahora (ORCID: https://orcid.org/0000-0002-3068-5050)
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-088867
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Medizinische Universität Wien